Dow closes above 14,000, hits 5-year high SAN

New Post Public Reply Private Reply Replies (0) Message Board
ruliquid

Dow closes above 14,000, hits 5-year high

ScreenHunter_05 Feb. 12 18.01


SAN FRANCISCO (MarketWatch) — U.S. stocks pushed against resistance levels Tuesday as blue chips, led by the financial sector, closed at levels not seen in more than five years.

The Dow Jones Industrial Average (DJI JIA) rose 47.46 points, or 0.3%, to close at 14,018.70, with 23 of 30 components finishing in positive territory. Tuesday’s close is the best since Oct. 12, 2007, and 1% off its record close of 14,164.53, set on Oct. 9, 2007. The index hit an intraday high of 14,038.97 on Tuesday.
Financial stocks boosted blue chips with Bank of America Corp. (NYSE:BAC) leading the way with a 3.3% gain. Shares of J.P. Morgan Chase & Co. (NYSE:JPM) rose 1%, Travelers Cos. (NYSE:TRV) advanced 0.9%, and American Express Co. (NYSE:AXP) closed 0.4% higher.

Coca-Cola Co. (NYSE:KO) was the worst performer on the Dow industrials, declining 2.7%, after the beverage giant’s quarterly revenue growth came in below analyst estimates. See: Coca-Cola profit rises 13% on higher case volume.

The S&P 500 index (SNC:SPX) advanced 2.42 points, or 0.2%, to 1,519.43, with technology the biggest decliner and financials the top gainer among the 10 major industry groups.
he Nasdaq Composite Index (NASDAQ:COMP) , after a brief swing into positive territory, closed down 5.51 points, or 0.2%, at 3,186.49.

Apple Inc. (NASDAQ:AAPL) shares ended near their lows of the session, down 2.5% at $467.90. The iPhone maker presented at a Goldman Sachs investment conference in San Francisco.

Apple CEO Tim Cook told investors at the conference that the company did not plan to wage a proxy battle against hedge-fund manager David Einhorn over a proposal to issue preferred stock.

Also in the tech sector, shares of Facebook Inc. (NASDAQ:FB) fell 3.2%.

The stock market is undergoing an epic struggle right now, having been in a secular bear market for the past 13 years, said Marty Leclerc, principal at Barrack Yard Advisors. With the stock market at multiyear highs, and multiyear resistance levels, we would need another 30% rally over the next year to break out of the bear market, he said. See Mark Hulbert’s commentary: An overlooked bear-market strategy.

“We do think it’s a dangerous tipping point,” Leclerc said. “Either the market will go up 30% in the next year or we’ll have a 20% to 25% decline from these levels.” http://www.marketwatch.com/story/coca-cola-dr...2013-02-12

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Understanding Adobe’s Recent Options Activity Results

Updated Category News Views 114

Adobe's Options Activity Highlights In the world of finance, significant trades often signal important market sentiments. Recently, major investors have moved toward a bearish outlook on Adobe. Analyzing the options history for Adobe (NASDAQ: ADBE), we've identified a total of 67 significant trades. Our insights reveal that approximately 41% of these trades have been...

Continue Reading
Indonesia's Ongoing Challenge with Chinese Maritime Presence

Updated Category News Views 130

Indonesia's Maritime Security Efforts Intensify Recently, Indonesia's maritime security has been under increased scrutiny as incidents involving a Chinese coast guard vessel continue to escalate. This week, a Chinese vessel was driven from Indonesian waters not once, but twice, after interfering with a critical energy survey conducted by Pertamina, the state energy...

Continue Reading
Revolutionizing Game Development with Upheaval Games' Dreamer Portal

Updated Category News Views 140

Welcome to the Future of Game Development Upheaval Games, founded by veterans from the gaming industry, embraces a new frontier in game design with the introduction of The Dreamer Portal. This innovative web-based interface allows creators to effortlessly build immersive game content with just a simple prompt. Imagine the power of crafting unique creatures, items, and...

Continue Reading
Alvotech Moves Forward with Gobivaz® Approval in Europe

Updated Category News Views 190

Alvotech and Advanz Pharma Collaborate for Biosimilar Approval REYKJAVIK and LONDON – Alvotech (NASDAQ: ALVO), a renowned biotechnology firm, along with Advanz Pharma, a leading global pharmaceutical company, has shared important news regarding the marketing approval of Gobivaz®, a proposed biosimilar to Simponi® (golimumab). This biologic treatment is designed for...

Continue Reading
Exploring the Growth Potential of Remote Patient Monitoring Sector

Updated Category News Views 181

Remote Patient Monitoring Set for Dynamic Growth The increasing prevalence of chronic conditions worldwide is expected to significantly accelerate the growth of the remote patient monitoring (RPM) market. As conditions like hypertension, diabetes, and cardiovascular diseases become more common, coupled with an aging population, healthcare systems face immense pressure to...

Continue Reading